Vincent Serra
Chief Operating Officer chez NEOVACS
Profil
Vincent Serra is the founder of Wittycell SAS, which was founded in 2005.
He held the title of Chief Executive & Scientific Officer from 2012 to 2014.
Dr. Serra's current job is as Chief Operations & Scientific Officer at Neovacs SA since 2019.
He is also currently Vice President at BioSupport AG.
Dr. Serra's former job was as Vice President-European Operations at Anosys, Inc. from 1999 to 2005.
He also worked at Abivax SA as VP-Research & Development Viral Vaccines Division.
Dr. Serra obtained a doctorate degree from the University of Grenoble.
Postes actifs de Vincent Serra
| Sociétés | Poste | Début |
|---|---|---|
| NEOVACS | Chief Operating Officer | - |
| BioSupport AG | Corporate Officer/Principal | - |
Anciens postes connus de Vincent Serra
| Sociétés | Poste | Fin |
|---|---|---|
Wittycell SAS
 Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Chief Executive Officer | 01/02/2014 |
Anosys, Inc.
 Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Corporate Officer/Principal | 01/02/2005 |
| ABIVAX | Corporate Officer/Principal | - |
Formation de Vincent Serra
| University of Grenoble | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NEOVACS | Health Technology |
| ABIVAX | Health Technology |
| Entreprise privées | 3 |
|---|---|
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Health Technology |
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Health Technology |
| BioSupport AG |
